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Abstract
Objectives Saliva can suppress osteoclastogenesis, but the un-
derlying mechanism has not been discovered yet. Considering
that endotoxins suppress osteoclastogenesis in bone marrow
cultures and that saliva contains endotoxins, it was reasonable
to hypothesize that the impact of saliva on osteoclastogenesis
requires toll-like receptor 4 signaling.
Material and methods To test this hypothesis, we blocked
toll-like receptor 4 signaling with TAK-242 in the presence
of saliva in murine bone marrow cultures. Osteoclastogenesis
was evaluated based on gene expression analysis and histo-
chemical staining for tartrate-resistant acid phosphatase.
Resorption was performed on dentine.
Results We report that TAK-242 reversed the inhibitory effect
of fresh sterile saliva on the formation of multinucleated cells
that stained positive for tartrate-resistant acid phosphatase. In
line with this finding, TAK-242 increased the expression of
the osteoclast functional genes cathepsin K, calcitonin recep-
tor, and tartrate-resistant acid phosphatase in the presence of
saliva. TAK-242 also supported the expression of NFATc1,
the master regulator of osteoclastogenesis, as well as DC-
STAMP and Atp6v0d2, both being cell fusion genes. In sup-
port of the hypothesis, depletion of saliva from endotoxin
partially reversed the inhibitory effect on osteoclastogenesis.
Moreover, salivary pellicle on plastic and titanium did not
affect osteoclastogenesis.
Conclusion Inhibition of toll-like receptor 4 signaling re-
vealed that saliva can contribute to innate immunity by
preventing hematopoietic progenitors to become osteoclasts.
Clinical relevance Saliva can activate pattern recognition re-
ceptor signaling through endotoxins and other stress factors,
indicating the demand for macrophages rather than for
osteoclasts.
Keywords Saliva . Toll-like receptor . Endotoxin .
Osteoclast . Murine bonemarrow . Dentistry
Introduction
Saliva is a complex pleiotropic biological fluid produced by
the salivary glands. The broad range of physiological func-
tions covers lubrication of the oral mucosa, enzymatic food
digestion [1], and formation of the pellicle layer [2]. Besides
the molecules produced by the glands, saliva also contains
products of the commensalistic microbiota, making this bio-
logical fluid even more complex in its composition [3]. Thus,
saliva has traditionally been used for diagnostic purposes in
oral pathology [4, 5] and in general medicine [4]. Diagnostic
assays have advanced from single analyst to screening ap-
proaches, including proteomics [6] and microbiomics [3].
What remains to be advanced are functional assays describing
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the cellular response to saliva and its components. Saliva
reaches all defect sites in the oral cavity, including the alveolar
bone after tooth extraction. Particularly, in vivo research with
desalivated rats showed a delay in socket healing and slower
bone remodeling [7, 8]. The molecular mechanism on how
saliva impacts bone in the oral microenvironment is unclear.
Functional assays revealed that saliva is a powerful inhib-
itor of osteoclastogenesis, while allowing the formation of
phagocytes in murine bone marrow cultures to occur [9].
The underlying molecular mechanisms are unknown. Saliva
also provokes a strong inflammatory response in oral fibro-
blasts [10, 11], which has recently been attributed to toll-like
receptor (TLR) 4 signaling [12]. This discovery was based on
TAK-242, a potent small-molecule-specific inhibitor of TLR4
signaling that was originally developed to cope with sepsis
[13]. Mechanistically, TAK-242 prevents the association of
TLR4 with adaptor proteins [14]. Saliva contains endotoxins
of gram-negative bacteria such as lipopolysaccharides that
activate TLR4. TAK-242 can thus be used to investigate the
role of TLR4 signaling to mediate the inhibitor effect of saliva
on osteoclastogenesis. Support for this assumption comes
from in vitro studies showing that lipopolysaccharides alone
are potent inhibitors of osteoclastogenesis in bone marrow
cultures [15, 16].
Osteoclastogenesis in bone marrow cultures can be
induced by the addition of two molecules, RANKL ini-
tiating the differentiation process and M-CSF promoting
the survival and expansion of the respective myeloid
progenitor cells [17]. TGF-β supports this process fur-
ther [18]. Differentiation requires signaling via RANK
[19] and the associated factor TRAF6 [20]. The path-
way increases the expression of the nuclear factor of
activated T cells c1 (NFATc1), the master regulators of
osteoclastogenesis [21]. Osteoclast fusion requires den-
dritic cell-specific transmembrane protein (DC-STAMP)
and ATPase, H+ transporting, lysosomal 38 kDa, and
V0 subunit d2 (Atp6v0d2) [22, 23], which is also reg-
ulated by NFATc1 at the transcriptional level.
Co-stimulatory molecules contribute to osteoclastogenesis
by activating the immunoreceptor tyrosine-based activation
motif (ITAM)-dependent pathway [24]. Osteoclast-
associated receptor (OSCAR) and triggering receptor
expressed in myeloid cells (TREM2) are receptors that are
associated with the adaptor molecules Fc receptor common
gamma chain (FcRγ) and DNAX-activating protein 12 kDa
(DAP12), respectively. Finally, osteoclasts are characterized
by multinuclearity and the expression of functional genes,
including tartrate-resistant acid phosphatase (TRAP), cathep-
sin K (CatK), and the calcitonin receptor (CTR). The expres-
sion of the respective genes provides insight into the process
of osteoclastogenesis in vitro. We show here that TAK-242
reversed the inhibitory effect of fresh sterile saliva on the
formation of osteoclasts.
Materials and methods
Saliva sampling and treatment
Human whole saliva was collected from the group of
authors who had no oral inflammation and were non-
smokers, as recently reported [9–11, 25]. Saliva flow
was stimulated chewing paraffin wax (Ivoclar Vivadent
AG, Schaan, Liechtenstein) and collected between 09:00
and 11:00 a.m. Saliva was centrifuged at 4000×g for
5 min, and filtered (0.22 μm PES syringe filter, TPP
AG, Trasadingen, Switzerland) samples were used. For
preparing a saliva pellicle [25], culture plates and tita-
nium disks (grade 4 titanium, machined surface; Institut
Straumann AG, Basel, Switzerland) were exposed to
whole saliva for 2 h, followed by two steps of vigorous
washing with phosphate-buffered saline [25].
In vitro osteoclastogenesis in bone marrow cultures
Bone marrow cells from 4- to 6-week-old female BALB/c
mice (Veterinary service, Department of Clinical Research,
University of Bern) were seeded at one million bone mar-
row cells per square centimeter in alpha modified Eagle’s
Minimum Essential Medium supplemented with 10% fetal
calf serum (FCS) and antibiotics after approval of the
Ethics Committee (No. BE76/12) of the University of
Bern. Receptor activator of nuclear factor kappa-B ligand
(RANKL, 30 ng/ml), macrophage colony-stimulating factor
(M-CSF, 30 ng/ml), and human transforming growth factor
beta1 (TGF-β1, 10 ng/ml) were used to induce osteoclas-
togenesis. All factors were obtained from ProSpec (Ness-
Ziona, Israel). If not otherwise indicated, 10% saliva was
included in the culture medium. Pharmacological blocking
was performed with 25 μM of TAK-242 (Merck
Millipore, Darmstadt, Germany). Endotoxin removal resins
were used to deplete saliva from lipopolysaccharides
(EndoTrap HD, Hyglos, Bernried, Germany). In indicated
experiments, bone marrow cells were exposed to 10 μg/ml
lipopolysaccharides (LPS) with or without TAK-242
(25 μM). After 5 days, histochemical staining for
tartrate-resistant acid phosphatase (TRAP, Sigma-Aldrich)
was performed. Cells with three or more nuclei were
counted positive for osteoclasts. For resorption assays,
bone marrow cells were seeded onto dentine slices for
5 days, with or without saliva and TAK-242. Prior to cell
seeding, dentine disks were cleaned with ultra-sonication
treatment and sterilized by UV light exposure. After
5 days, cells were detached with sodium hypochlorite
(10 min) and ultra-sonication (30 min). Resorption lacunae
were imaged via scanning electron microscopy at 100-fold
magnification (JSM-6010PLUS/LA, Jeol, Japan) (Table 1).
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Expression of marker genes in bone marrow cultures
Total RNA was isolated using the High Pure RNA Isolation
Kit (Roche Applied Science, Rotkreuz, Switzerland). Reverse
transcription (RT) was performed with Transcriptor Universal
cDNA Master, and PCR was performed with TaqMan
Universal PCR Master Mix (Applied Biosystems, Carlsbad,
CA, USA) or the FastStart Universal Probe Master Rox on a
7500 Real-Time PCR System (Roche). Probes for CTR,
TRAP, CatK, OSCAR, TREM2, FcRγ, DAP12, and beta ac-
tin were obtained from the TaqMan Gene Expression Assays
service (Applied Biosystems). In all experiments, the FastStart
Universal SYBR Green Master Rox (Roche) was used. All
other primers were designed with the online Universal
ProbeLibrary System (Table 2) [9]. The messenger RNA
(mRNA) levels were calculated by normalizing to the house-
keeping gene beta actin using the ΔΔCt method.
Cell viability and proliferation
Bone marrow cells were stimulated with the selected prepara-
tions for 5 days and subjected to viability or proliferation
assays. The viability measures were determined via formazan
formation assay (Sigma, St. Louis, USA), Live-Dead Staining
Kit from Enzo Life Sciences AG (Lausen, Switzerland), and
the DNA incorporation of 5-Bromo-2´-Deoxyuridine (BrdU)
Cell Proliferation ELISA Kit (Roche Life Science, Penzberg,
Germany).
Statistical analysis
Data were compared using ANOVA and Student’s t test. For
post hoc analysis, the p value was adjusted according to the
Tukey’s test. At least three different experiments with two
donors were performed if not indicated otherwise. Statistical
analysis was performed using GraphPad Prism 6.0 (GraphPad
Software Inc., San Diego, USA), p < 0.05.
Results
TAK-242 reversed the inhibitory effect of sterile saliva
on osteoclastogenesis
To examine the influence of endotoxins within saliva on oste-
oclastogenesis, murine bone marrow cells were grown in the
presence of TAK-242, besides the factors RANKL, M-CSF,
and TGF-β. As reported recently, saliva is a potent suppressor
of osteoclastogenesis, indicated by the formation of TRAP-
positive multinucleated cells [9]. Importantly, TAK-242 re-
versed the inhibitory effect of sterile saliva and LPS on oste-
oclastogenesis, shown by the expression of osteoclast genes
Catk, TRAP, and CTR. Thus, blocking TLR4 signaling with
TAK-242 allowed osteoclastogenesis in the presence of saliva
(Fig. 1) and LPS (Suppl. Fig. 1). Salivary pellicle on plastic
and titanium did not affect the formation of TRAP-positive
multinucleated cells (Fig. 2a, b) and the expression of osteo-
clast genes CatK, TRAP, and CTR (Fig. 2c), even though the
pellicle delayed adhesion of cells within the first 24 h (data not
shown).
Table 1 Relative gene expression of osteoclast-like cells exposed to
autoclaved saliva
Gene autoclaved
saliva (121 °C)
SD Autoclaved
saliva (121 °C) +
TAK-242 (25 μM)
SD
CatK 0.01* 0.01 1.16 0.23
TRAP 0.01* 0.01 0.71 0.03
CTR 0.00* 0.00 0.28 0.10
Osteoclast-like cells were exposed to heated sterile saliva (121 °C), with
or without 25 μM of TLR4-receptor inhibitor TAK-242. Data represent
the gene expression relative to the untreated control
*p values <0.05
Table 2 Primer sequences of the
investigated genes Gene Forward primer Reverse primer Reference
m βactin ctaaggccaaccgtgaaaag accagaggcatacagggaca [9]
mRANK gtgctgctcgttccactg agatgctcataatgcctctcct [9]
m c-fos gcaactttctatgacactgaaacac tctctctagggctgcattgg [9]
mNFATc-1 ccgttgcttccagaaaataaca tgtgggatgtgaactcggaa [9]
mDC-Stamp aagctccttgagaaacgatca caggactggaaaccagaaatg [9]
mAtp6Od2 aagcctttgtttgacgctgt gccagcacattcatctgtacc [9]
mTRAF6 ttgcacattcagtgtttttgg tgcaagtgtcgtgccaag [9]
mCXLC2 aaaatcatccaaaagatactgaacaa ctttggttcttccgttgagg [9]
mCCL2 catccacgtgttggctca gatcatcttgctggtgaatgagt [9]
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Fig. 2 Saliva pellicle does not
affect osteoclastogenesis. Murine
bonemarrow cultures were grown
onto salivary pellicle on plastic
and titanium with an
osteoclastogenesis inducer
cocktail consisting of RANKL,
M-CSF, and TGF-β (RMT).
Salivary pellicle did not affect
formation of multinucleated
TRAP+ cells on plastic (a, b).
Expression of osteoclast
functional genes CatK, TRAP,
and CTR was not affected by
salivary pellicle (a). Data were
normalized to positive expression
levels of RMT cultures. Bars
represent the mean ± standard
deviation of in total five
experiments. Not indicated are
p values >0.1
Fig. 1 TAK-242 reversed the inhibitory effect of sterile saliva on
osteoclastogenesis. Bone marrow cells from mice were grown with and
without the presence of the TLR4 inhibitor TAK-242, in the presence of
an osteoclastogenesis inducer cocktail consisting of RANKL, M-CSF,
and TGF-β (RMT). Osteoclastogenesis is indicated by histochemical
staining of TRAP in multinucleated cells. Bars represent 100 μm.
TAK-242 greatly reversed the inhibitory effect of saliva on
osteoclastogenesis (a, b). In support of the histological picture, also the
expression of osteoclast functional genes CatK, TRAP, and CTR was
increased by TAK-242, even reaching the levels of controls with no
saliva (c). Data were normalized to positive expression levels of RMT
cultures. Bars represent the mean ± standard deviation of in total five
experiments. Not indicated are p values >0.1
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TAK-242 blocked the effect of saliva on the master
regulator of osteoclastogenesis and the fusion genes
To investigate the impact of blocking TLR4 signaling on
downstream mechanisms, TAK-242 was tested for changing
gene expression of the RANK–RANKL signaling pathway.
According to the overall hypothesis, TAK-242 competed with
saliva for the expression of RANK, TRAF6, and the respec-
tive downstream master regulator NFATc1 (Fig. 3). TAK-242
also reversed the inhibitory and stimulatory effect of saliva on
expression of OSCAR and FcRg, respectively (Fig. 4a).
Moreover, TAK-242 increased DC-STAMP and Atp6v0d2
expression, which was markedly decreased by saliva
(Fig. 4b). Accordingly, the increased mRNA expression of
CXCL2 and CCL2 in response to saliva was blocked by
TAK-242 (Fig. 4c). In addition, resorption assays revealed
that TAK-242 canceled the inhibitory effect of saliva to the
resorption capacity of osteoclast-like cells (Fig. 7). Overall,
TAK-242 blocked the inhibitory effect of saliva and LPS on
osteoclastogenesis in murine bone marrow cultures.
Fig. 3 TAK-242 blocked the effect of saliva on the master regulator of
osteoclastogenesis and the fusion genes. When bone marrow cells were
grown in the presence of TAK-242, the suppressed expression of the
signaling molecules RANK, TRAF6, and NFATC1 was reversed,
reaching levels of control cultures without saliva. Data were normalized
to positive expression levels of RMT cultures. Bars represent the
mean ± deviation of in total five experiments. Not indicated are
p values >0.1
Fig. 4 TAK-242 also reversed the inhibitory and stimulatory effect of
saliva on expression of OSCAR and FcRg, respectively (a). Moreover,
TAK-242 increased DC-STAMP and Atp6v0d2 expression, which are
markedly decreased by saliva (b). Accordingly, the increased mRNA
expression of CXCL2 and CCL2 in response to saliva was blocked by
TAK-242 (c). Data were normalized to positive expression levels of RMT
cultures. Bars represent the mean ± standard deviation of in total five
experiments. Not indicated are p values >0.1
Fig. 5 Endotoxin removal from saliva supports osteoclastogenesis.
Osteoclasts were exposed to saliva or to saliva pre-treated with
endotoxin removal resins. Saliva decreased Catk, TRAP, and CTR gene
expression to a significant level. Saliva prior to treatment with endotoxin
removal resins increased marker genes’ expression significantly
compared to saliva alone. Data were normalized to positive expression
levels of RMT cultures. Bars represent the mean ± standard deviation of
in total five experiments. Not indicated are p values >0.1
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Endotoxin removal from saliva supports
osteoclastogenesis
Endotoxin removal was performed to further prove that the
inhibition of osteoclastogenesis is a consequence of endo-
toxins in saliva. As indicated in Fig. 5, saliva being at least
partially depleted from endotoxins had a less inhibitory effect
on osteoclastogenesis than the respective original unprocessed
saliva. Further support for the role of endotoxins comes from
experiments with saliva heated up to 120 °C that was still
capable to suppress osteoclastogenesis (Table 1) and LPS-
exposed osteoclast experiments (Suppl. Fig. 1). Live-dead
staining and proliferation assays further indicated that neither
saliva nor TAK-242 causes any adverse reaction in the in vitro
system (Suppl. Fig. 2). Taken together, experiments with en-
dotoxin removal and heating of saliva point towards a role of
endotoxins in mediating at least some of the effects of saliva
on osteoclastogenesis. A schematic singling cascade including
TAK-242 is provided in Figs. 6 and 7.
Discussion
The major findings of the present study are that blocking
in vitro osteoclastogenesis by saliva requires TLR4 signal-
ing. Basically, the TLR4 inhibitor TAK-242 completely
reversed the cellular response to saliva in vitro [9].
Further support for this hypothesis comes from observa-
tions that endotoxin removal from saliva supports osteo-
clastogenesis and from the resistance of the respective
activity in saliva against heating. The findings are substan-
tial because they point towards endotoxins of the
commensalistic oral microbiota, thereby not ruling that al-
so exocrine molecules of the salivary glands through
TLR4 signaling target hematopoietic stem cells. The ques-
tion how the hematopoietic stem cells respond to saliva at
the molecular level is starting to be answered.
Saliva provokes a massive inflammatory response in oral
fibroblasts [10, 11, 25]. Originally, blocking peptides raised
against TLR4 and the downstream mediator MYD88 failed to
reverse the inflammatory response [9], but TAK-242 was suc-
cessful in this regard [12]. Saliva proteins including alpha-
amylase, prolactin-inducible protein, and cystatin serve as car-
riers for endotoxins [26, 27], and LPS suppresses RANK ex-
pression in macrophages [28]. Also in agreement with the
present findings, salivary pellicle does not suppress osteoclas-
togenesis and does not show a pro-inflammatory activity [25].
Fig. 6 Schematic illustration of the TLR4 signaling pathway (a) and
inhibition via TAK-242 (b). TLR4 signaling depends on MyD88- and
TRIF-dependent signaling pathway. TAK-242 blocking the intracellular
domain of TLR4. Thereby, TAK-242 interferes with interactions between
TLR4 and its adaptor molecules, TIRAP and TRAM [14]
Fig. 7 Resorption lacunae of osteoclast-like cells exposed to saliva and
TAK-242. Bone marrow cells were seeded on dentin disks for 5 days in
RMT medium. Cells were stimulated with or without sterile saliva and
TLR4 inhibitor TAK-242. To detach the cells, dentine disks were treated
with sodium hypochlorite and ultra-sonication. Resorption lacunae were
imaged via scanning electron microscopy at a 100-fold magnification.
Saliva exposed osteoclast-like cells showed any contribution to dentine
resorption compared to saliva-exposed cells co-stimulated with TAK-242
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Our data are also in line with the fundamental research that
LPS alone suppresses osteoclastogenesis in bone marrow cul-
tures [15, 16, 29], but not in other in vitro systems with com-
mitted progenitors such as RAW 264 cells [30]. LPS even
increases osteoclastogenesis when cells are committed to be-
come osteoclasts [16]. Nevertheless, the present findings do
not rule out that other, as yet undefined molecules in saliva
suppress osteoclastogenesis.
The clinical relevance has to be interpreted with care, as the
role of osteoclastogenesis in oral sciences has not yet been
resolved. However, osteoclastogenesis might play a role after
tooth extraction or in other situations where bone is exposed to
saliva. For example, in vivo animal models targeting the sock-
et healing capacity of desalivated rats show that without saliva
socket healing after tooth extraction is delayed [7]. In the
absence of saliva, replacement of the blood clot with granula-
tion tissue is delayed including fewer collagen fibers and cells
at the defect side [7]. Osteoclasts originate from hematopoietic
progenitors that can be isolated from blood and are not re-
stricted to the bone marrow. Thus, the murine bone marrow
culture is not the exclusive bioassay for osteoclasts and does
not necessarily represent the situation in a tooth extraction site.
While bone marrow is a source of highly undifferentiated
hematopoietic stem cells, the blood contains mainly mono-
cytes that can become osteoclasts in vitro [31]. Thus, we can-
not rule out that saliva modulates osteoclastogenesis in mono-
cyte cultures. Nevertheless, we revealed some basic principles
of TLR4 signaling activated by saliva in bone marrow cul-
tures, observations that exceed the possible relevance of oste-
oclastogenesis, pointing towards a differentiation shift of he-
matopoietic stem cells into a macrophage lineage that is in-
volved in the early stages of wound healing, including defects
of the oral cavity. Support for this hypothesis comes from our
recent research showing that saliva supports polarization of
macrophages into the pro-inflammatory M1 phenotype [32].
The present findings, therefore, have to be interpreted in the
sense of a functional assay using osteoclastogenesis as a read-out
for understanding the biological potential of saliva and the dif-
ferentiation between the molecules produced in the glands and
endotoxins from the microbiota. Caution should be taken in con-
cluding that endotoxins in saliva act as Banti-resorptive^ compo-
nents, considering that the bone marrow culture does not neces-
sarily represent the clinical situation where committed progeni-
tors appear at the defect site. In this situation, endotoxins in saliva
most likely support osteoclastogenesis. Nevertheless, saliva stim-
ulates oral wound healing [8, 33] and, considering that inflam-
mation is part of wound healing, salivamight contribute to innate
immunity by preventing macrophage progenitors to become os-
teoclasts, as the process involves activation of pattern recognition
receptor signaling.
The limitation of the study is that the biological relevance
of our findings remains to be clarified. The data, however,
should encourage considering endotoxins within saliva to act
as a bioactive component that is part of the physiological
composition of saliva. Endotoxins in saliva might have a po-
tential beneficial effects related to the innate immune system,
which is triggered by the activation of the pattern recognition
receptors—including TLR4 [34]. However, the data should
not be interpreted only towards endotoxins, as saliva holds a
myriad of bioactive proteins that might contribute to the
TLR4-mediated cell response. It would thus be interesting to
investigate the impact of saliva from sterile animals on osteo-
clastogenesis and, based on these preclinical models, to study
the role of saliva on wound healing, including extraction sites.
Future studies should therefore include more functional assays
allowing the differentiation of effects of saliva components
from the gland and those from the microbiom, helping to
decipher the biological function of saliva in oral sciences.
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